Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Be the Difference Foundation to Raise Money for 12 Ovarian Cancer Clinical Trials
Be The Difference Foundation has launched its 12 Clinical Trials for Christmas campaign, an effort to provide clinical trials for 12 women battling ovarian cancer. Be The Difference Foundation’s 12 Clinical Trials for Christmas campaign not only raises money to cover the cost of a clinical... - December 11, 2019 - Be the Difference Foundation
New World Medical Named Among the Inland Empire Top Workplaces
New World Medical, a global medical company focused on glaucoma treatment, has been listed in the Inland Empire Top Workplaces 2019 organized by Inland News Group. The Top Workplaces list is based on an anonymous survey administered by the Energage platform, which measures several aspects of... - December 09, 2019 - New World Medical
The ASAcampus Team Takes Part in XENOGRISS, One of the Italian Experiments by the Italian Space Agency, for the ESA Beyond Mission
The Space-X 19 was launched at 12:29 EST on December 5 last; on-board it carries some scientific experiments that will be undertaken on the International Space Station during the Beyond Mission, led by the Italian astronaut Luca Parmitano from the European Space Agency. - December 08, 2019 - ASA srl
CureTalks@UCSFCancer Puts Patients at the Center, with Live and Archivable Internet Radio Talk Shows Featuring Patients, Advocates and Leading Oncology Researchers
CureTalks, an internet radio and video podcasting service of TrialX, features leading physicians in conversation with patients, caregivers, and patient advocates. The University of California, San Francisco Helen Diller Family Comprehensive Cancer Center (HDFCCC) is the most recent institution to... - December 04, 2019 - TrialX
ALPCO Announces Deadline for Winter 2020 Diabetes Research Travel Grant Award
ALPCO announced the submission deadline for its Winter 2020 Diabetes Research Travel Grant Award. Each recipient is awarded up to $2500 to present their research at a relevant conference and a $2500 product credit. - December 04, 2019 - ALPCO
Dr. Amishi Desai Joins New York Cancer & Blood Specialists in Suffolk
New York Cancer & Blood Specialists (NYCBS) is proud to announce Amishi Desai, MD to its team. Dr. Desai is board-certified in hematology-oncology, as well as internal medicine. As such, she covers a full scope of services, while also maintaining a particular interest in lung cancer. In... - December 03, 2019 - New York Cancer & Blood Specialists
CLL Society to Present Innovative Telemedicine Platform Study at American Society of Hematology Annual Conference
CLL Society co-founder and Medical Director Dr. Brian Koffman will present research results of the society's innovative telemedicine program at the prestigious American Society of Hematology annual meeting in early December. The program provides patients and caregivers access to HIPPA-compliant second opinions from renowned specialists in chronic lymphocytic leukemia (CLL), the most common adult blood cancer. - November 30, 2019 - CLL Society
Rose Center for Bariatrics Recognized Among the Top 5% in Nation for Bariatric Surgery
Rose Medical Center receives multiple bariatric surgery top honors from Healthgrades. - November 29, 2019 - Rose Medical Center
New York Imaging Specialists Announces Grand Opening in Port Jefferson Station
New York Imaging Specialists announces the grand opening of its newest facility, at 1500 Route 112, Building 2A in Port Jefferson Station, NY 11776. New York Imaging Specialists features board-certified radiologists and the most modern imaging equipment. The ACR-accredited facility utilizes... - November 28, 2019 - New York Imaging Specialists
Dr. Varghese Cherian Joins New York Imaging Specialists
New York Imaging Specialists welcomes Varghese Cherian, MD, to its group of board-certified radiologists. Dr. Cherian will be practicing at New York Imaging Specialists’ newest facilities at 1500 Route 112, Building 2A in Port Jefferson Station and 640 County Road 39 in Southampton. Dr. - November 28, 2019 - New York Imaging Specialists
Kidney Care Community Encouraged by New USRDS Data, Stresses the Need for Continued Improvement
The latest United States Renal Data System (USRDS) report underscores the need to expand education and early detection efforts to improve health outcomes. - November 27, 2019 - Kidney Care Partners
AT-1501, a Drug Discovered at the ALS Therapy Development Institute, Completes Phase I Trials
The ALS Therapy Development Institute (ALS TDI), a non-profit biotechnology company dedicated to the discovery and development of effective treatments for ALS, is pleased to share that AT-1501, a drug discovered and developed in the ALS TDI lab, has successfully completed Phase I clinical trials. - November 20, 2019 - ALS Therapy Development Institute
Varicose Veins Doctors Provide Minimally Invasive Treatment Procedures for Varicose Veins
Varicose Veins Doctors is a reputable vein treatment center in Manhattan, NY. The clinic has gained a reputation for its exceptional patient care and a wide range of effective treatment options for vein diseases. Their teams of experts use state-of-the-art equipment to perform complex procedures for pain relief. - November 20, 2019 - Varicose Veins Doctors
Phase III Clinical Study of Valbenazine for Chorea in Huntington Disease
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. - November 14, 2019 - Huntington Study Group
Bold Health Partners with the University of Pennsylvania for Clinical Trial of Its Zemedy IBS App
The School of Arts and Science of the prestigious University of Pennsylvania has tendered a public invitation for suitable individuals to participate in a waitlist randomised control trial aimed at investigating the potential benefits of the Zemedy mobile app in patients with Irritable Bowel... - November 13, 2019 - Bold Health
Global Regenerative Group Enters Into Distribution Partnership with Aurafix & Remodem
Global Regenerative Group, a proven company in the field of medicine and innovation, is pleased to announce partnerships with Remodem and Aurafix. - November 09, 2019 - Global Regenerative Group
ALPCO Launches Analytically Specific Human and Rodent STELLUX® Glucagon ELISA
ALPCO's new STELLUX® Chemiluminescence Glucagon ELISA features increased analytical specificity and a broad range to accurately quantify glucagon levels between 0.86 and 143.7 pmol/L (3-500 pg/mL) in human and rodent samples. - November 06, 2019 - ALPCO
OrthoNeuro Spine Surgeon Performs the First Robotics-Assisted Minimally Invasive 2-Level Lumbar Interbody Fusion Surgery in Central Ohio at Mt. Carmel St. Ann’s Hospital
Dr. Ying Chen, OrthoNeuro Neurosurgeon, completed the first robotics-assisted minimally invasive 2-level interbody fusion surgery in Central Ohio. This surgical milestone occurred on October 28, 2019 using the Globus Excelsius GPS Robotic Navigation System. - November 06, 2019 - OrthoNeuro
Cephasonics Ultrasound Awarded Competitive Grant from the National Science Foundation for Ultrasound Research
Cephasonics Ultrasound has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant to conduct research and development (R&D) toward developing a new computational architecture for AI-enabled Ultrafast Frameforming ultrasound systems (UFFFI) - November 04, 2019 - Cephasonics Ultrasound
ALPCO’s New Fecal Calprotectin ELISA with Superior Clinical Accuracy Receives FDA 510(k) Clearance
ALPCO received 510(k) clearance from the US FDA for its new fecal Calprotectin Chemiluminescence ELISA test. The ALPCO Calprotectin Chemiluminescence ELISA’s superior clinical accuracy will enable clinical laboratories to provide the most accurate results to gastroenterologists facing the challenges of differentiating IBD from IBS. - October 30, 2019 - ALPCO
NYCBS Welcomes Dr. Keith Brunckhorst to Its Oncology Team
Keith R. Brunckhorst, MD is a talented physician who is board-certified in medical oncology and hematology. He is experienced and well versed in the most cutting-edge cancer technology, with an impeccable work history and education. For Dr. Brunckhorst, patients come first. He pledges to treat each... - October 17, 2019 - New York Cancer & Blood Specialists
NextHealth’s Executive Advisory Council Tackles How Payers Are Measuring and Optimizing Their Clinical Portfolios for Reduced Costs and Improved Outcomes
Analytics shine a spotlight on the initiatives that deliver value and how to integrate resulting insights into workflow. - October 17, 2019 - NextHealth Technologies
Sky Ridge Medical Center Awarded Thrombectomy-Capable Stroke Center Certification from The Joint Commission
Sky Ridge Medical Center has earned The Joint Commission’s Gold Seal of Approval® and the American Stroke Association’s Heart-Check mark as a Thrombectomy-Capable Stroke Center. - October 16, 2019 - Sky Ridge Medical Center
IDI Consulting Raises Blood Cancer Awareness & Funds Through Light The Night Walk
Local IT consulting company participates in fourth year of fundraising efforts for The Leukemia & Lymphoma Society. - October 12, 2019 - IDI Consulting
Aciont Issued Key Patent Covering the Novel Design of the Visulex Ocular Drug Delivery Device
Aciont was issued a U.S. patent that covers an important aspect of the novel design of its main Visulex ocular drug delivery system which has been tested for safety and efficacy in its lead clinical program under U.S. IND. - October 12, 2019 - Aciont Inc.
HCA Healthcare/HealthONE’s Swedish Medical Center First in Colorado to Offer Minimally Invasive Surgery to Remove Blood Clot from Brain
New Procedure Quickly Removes Blood from Brain after Intracerebral Hemorrhage. - October 11, 2019 - Swedish Medical Center
NYCBS' CEO to Receive Humanitarian of the Year Award from the American Red Cross
New York Cancer & Blood Specialists (NYCBS) announced that their own CEO, Jeff Vacirca, MD, will be the 2019 American Red Cross Greater New York Region’s Humanitarian Award recipient. Dr. Vacirca will be honored on Wednesday, Oct. 16, 2019 at the 2019 Heroes Among Us Gala at the Ziegfeld... - October 10, 2019 - New York Cancer & Blood Specialists
ZKSciences Plant Growth Accelerator Technology Enters Formal Trials
ZKSciences has started formal third-party plant trials of its patent-pending ZK GrowFactor(TM) plant growth accelerator technology. ZK GrowFactor is a family of engineered zeolites that have shown phenomenal potential for increasing plant yields, improving the appearance of flowers and ornamental... - October 03, 2019 - ZKsciences
Tickets Now on Sale for The 19th Annual Dancing for Diabetes Show
Dancing for Diabetes has raised nearly half a million dollars for Type 1 Diabetes research. The 19th Annual Dancing for Diabetes Show will be held on Saturday, November 9 at the Bob Carr Theater in Orlando, Florida. - October 03, 2019 - Dancing for Diabetes
Swedish Medical Center First in Colorado to Use New Treatment for Brain Aneurysms
Rocky Mountain region neuroscience center of excellence introduces technology to treat challenging aneurysms with positive benefits for patients. - September 30, 2019 - Swedish Medical Center
VOS Digital Media Group Now Offering Health Content from Harvard Health Publishing
Harvard Health Publishing Provides Expert Health Information and Advice. - September 24, 2019 - Icaro Media Group
APTQI Urges CMS to Protect Seniors from Debilitating Falls by Preserving Medicare Reimbursement for Physical Therapy
Recognizing Falls Prevention Awareness Day 2019, APTQI is advocating for greater patient access to fall prevention tools such as manual and exercise therapy. - September 23, 2019 - Alliance for Physical Therapy Quality and Innovation
National Institutes of Health Selects Eva Garland Consulting to Lead Applicant Assistance Program
EGC will provide expert coaching to hundreds of companies seeking NIH SBIR/STTR funding. - September 23, 2019 - Eva Garland Consulting
A Year After the Launch of Ayushman Bharat Yojana; Medical Devices, Pharma Industries in India Expected to Benefit Substantially: Whitepaper by Nexdigm (SKP)
In 2017, the Indian Government introduced a National Health Policy (Ayushman Bharat or Healthy India) that aims to offer universal health coverage and provide the foundation for equitable healthcare. In this paper, SKP examines the potential of the NHPS and attempts to study the impact it creates on healthcare accessibility along with opportunities created for various stakeholders in the industry. - September 22, 2019 - Nexdigm
DNAtix Launches Free Anonymous Genetic Vault
Digital DNAtix Ltd., the Israeli cyber genetics startup, has announced the first free anonymous genetic vault service. DNAtix developed the Cyber Genetics Smart Platform for Digital Genetics. Lack of privacy is currently a barrier for so many people who want to have their DNA tested but are afraid to give their genetic data away. As of today anyone can anonymously upload their raw file from 23&Me and Ancestry.com onto the DNAtix platform. - September 17, 2019 - Digital DNAtix Ltd.
Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant® Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Protein
Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant®, is established for the high-level expression of homogeneously folded disulfide bond containing proteins in the cytoplasm of E. Coli. The technology offers all cost benefits of... - September 10, 2019 - Paras Biopharmaceuticals Finland Oy
Global Regenerative Group & Kanfit3D Enter Into Distribution Partnership
Pleased to announce a new distribution partnership between Global Regenerative Group, a company which has developed extensive experience in the most advanced medical device industries, and Kanfit3D. - September 05, 2019 - Global Regenerative Group
Emerge Diagnostics and DoctorsNow Announce Partnership for Doctor Triage and Virtual Wellness Clinics
Emerge Diagnostics has partnered with DoctorNow to offer a customized DoctorTriage and Virtual Wellness Clinics to enhance the Electrodiagnostic Functional Assessment Soft Tissue Management (EFA-STM) Program. The purpose of this program is to offer companies and employees access to doctors for... - September 04, 2019 - Emerge Diagnostics
3rd Annual Perthes Conference to be Hosted on October 5 at the Texas Scottish Rite Hospital for Children in Dallas, TX
On Saturday, October 5th at 8AM CST, the Legg Calve Perthes Foundation, alongside a team of parent volunteers, have partnered with the International Perthes Study Group (IPSG) to host a full day event to discuss the impact of Perthes Disease. The conference is designed to empower families with... - August 29, 2019 - Legg Calve Perthes Foundation
Construction Equipment Operator's Bum Knee "Just Perfect" After Stem Cell Therapy Provided by Kansas Regenerative Medicine Center
Orthopedic surgeon insisted that knee replacement surgery was the only way to fix construction equipment operator's bad knee. Stem cell treatment using a patient's own stem cells improved the bad knee and four years later, the knee has given the patient no problems. - August 22, 2019 - Kansas Regenerative Medicine Center
Neil Foley Joins NYCBS as a Physician Liaison
New York Cancer & Blood Specialists (NYCBS) proudly welcomes Neil Foley, a talented and experienced pharmaceutical representative to its city team as a physician liaison. Foley will bring over 21 years of experience of pharmaceutical expertise. He will be working out of NYCBS’ Bronx,... - August 20, 2019 - New York Cancer & Blood Specialists
APFED Invites Scientific Community to Apply for Research Grant Funding
Community Donations to APFED Will Fund New Research of Eosinophil-associated Diseases - August 15, 2019 - APFED
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
8-year Study Tracks Central Lab Performance and Identifies Covance as Leading the Way in Clinical Investigator Satisfaction. - August 13, 2019 - Life Science Strategy Group, LLC
VOS Digital Media Group Announces Partnership with Medical News Minute
Medical News Minute is the source for information and innovation in healthcare. - August 07, 2019 - Icaro Media Group
Advances in Medicine Cause New, Groundbreaking Drug by Quantum Genomics (QNNTF) to Help with Chronic Hypertension
Quantum Genomics are the creators of Firibastat, a first-in-class brain aminopeptidase inhibitor (BAPAI) that could potentially treat treatment-resistant hypertension by acting in the brain to interfere with the renin-angiotensin system. It is estimated that there are around 150 million people... - August 05, 2019 - Quantum Genomics
Brewing a Cure 4 ALS Fundraiser Invites You to Enjoy Regional Beers and Wines While Fundraising for ALS Research
On Saturday, August 10, 2019, the first-ever Brewing a Cure 4 ALS fundraiser will be held at Technology Square in Cambridge, MA. Brewing a Cure 4 ALS invites community members to enjoy craft beer, wine, music, and food with the goal of raising money for ALS research at the ALS Therapy Development... - July 31, 2019 - ALS Therapy Development Institute
NYCBS Set to Open New 347 Treatment Center
New York Cancer & Blood Specialists (NYCBS) will announce the grand opening of its newest treatment facility, at 49 Route 347, in Port Jefferson Station on Monday, July 29th, 2019. Located on Long Island’s scenic North Shore, the center will feature the most advanced cancer treatment on... - July 27, 2019 - New York Cancer & Blood Specialists
Immundiagnostik, Inc., North American Subsidiary of German Immunoassay Company, to Highlight 5 IVD Products at the AACC Scientific Meeting & Lab Expo in Anaheim, CA
Immundiagnostik, Inc., the North American subsidiary of the immunoassay development company Immundiagnostik AG based in Bensheim, Germany, will highlight 5 products for IVD Use at the AACC’S 71ST Annual Scientific Meeting & Clinical Lab Expo in Anaheim, CA.The list of products covers the gastrointestinal, metabolic syndrome & immunology arenas for laboratories in the United States. - July 18, 2019 - Immundiagnostik, Inc.
Biocair Germany GmbH Joins BioRN
Biocair Germany Gmbh is delighted to announce its membership to BioRN, one of Germany’s largest life science hubs. - July 16, 2019 - Biocair
Biocair Hosts Workshop with The Wellcome Sanger Institute
Specialist global courier to the life sciences sector, Biocair, is pleased to announce that it hosted an interactive workshop on Friday 5th July 2019 at The Wellcome Genome Campus in Cambridge (UK). - July 15, 2019 - Biocair